AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Cyclerion Therapeutics, Inc. Director's Dealing 2021

May 20, 2021

35315_dirs_2021-05-19_c1f28d79-8e63-4bd1-b03d-25d6b6c85310.zip

Director's Dealing

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Cyclerion Therapeutics, Inc. (CYCN)
CIK: 0001755237
Period of Report: 2021-04-21

Reporting Person: DESOUZA ERROL B (N/A)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	0	Direct